THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
发明人:
BANDALA SANCHEZ, ESTHER,DROMEY, JAMES,HARRISON, LEONARD CHARLES,ZHANG, YUXIA,RASHIDI, MARYAM
申请号：
CA2852133
公开号：
CA2852133A1
申请日:
2012.11.15
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases such as type 1 diabetes. The present disclosure also relates to fusion proteins comprising the soluble glycoprotein, to cells expressing high levels of CD52, and to diagnostic methods based on the detection of CD52 expression levels in a subject.
